Amyris, which started trading on the NASDAQ today, has racked up hundreds of millions of dollars from a bunch of investors since its founding in 2003, including venture capitalists Kleiner Perkins, Khosla Ventures, and French oil giant Total. For some of those backers who took a chance on the greentech venture early on, Amyris’ IPO offers a decent exit.
How good? Well, Amyris’ selling stockholders, directors, officers and employees are subject to a lock-up period for 180 days after the IPO, but at the IPO price of $16 per share, Kleiner’s 12.2 percent share is worth about $67 million and Khosla Venture’s 11.4 percent stake is worth around $62 million (I’m simplifying that). I’m not sure how much each firm put in, but Kleiner and Khosla each invested in Series A, B, and C rounds. Here’s the rundown:
| Shareholder | Pre-IPO Stake | Value of shares at $16 |
|---|---|---|
| Kleiner Perkins | 4.18M (12.2 percent) | $66.88M |
| Khosla Ventures | 3.89M (11.4 percent) | $62.24M |
| TPG Biotechnology Partners | 3.26M (9.5 percent) | $52.16M |
| Temasek Holdings | 2.72M (8 percent) | $43.52M |
| Advanced Equities | 1.79M (5.2 percent) | $28.64M |
| Amyris CEO John Melo | 1.50M (4.2 percent) | $24M |
| Amyris Co-founder Kinkead Reiling | 985K (2.9 percent) | $15.76M |
| Total Gas & Power | 7.10M shares (20.7 percent) | $113.60M |
For more research on cleantech financing check out GigaOM Pro (subscription required):

{"source":"https:\/\/gigaom.com\/2010\/09\/28\/who-wins-in-amyris-ipo\/wijax\/49e8740702c6da9341d50357217fb629","varname":"wijax_71ec2817574e447a3c740b1fceaee03f","title_element":"header","title_class":"widget-title","title_before":"%3Cheader%20class%3D%22widget-title%22%3E","title_after":"%3C%2Fheader%3E"}